Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin versus Triesence at cataract surgery for diabetic macular oedema
ACTRN12611000888965Phase 2Recruiting
- Sponsor
- The Royal Victorian Eye and Ear Hospital
- Start
- Feb 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label trial of bevacizumab and triamcinolone acetonide in diabetic macular edema (DME) (2 arms), sponsored by The Royal Victorian Eye and Ear Hospital. Primary endpoint: Best corrected visual acuity. Started Feb 2012; status: recruiting.
02
Drugs
bevacizumabtriamcinolone acetonide
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on ACTRN12611000888965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000888965.